SCHEMBL7085950

SCHEMBL7085950

FC(F)(F)c1c[c]nc2cccnc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 4/20 0.37
SLC40A1 Q9NP59 5/20 0.36
MEN1 O00255 1/20 0.35
TNF P01375 1/20 0.35
CXCL8 P10145 1/20 0.35
KMT2A Q03164 1/20 0.35
PAX8 Q06710 1/20 0.35
KLF5 Q13887 1/20 0.35
BACE1 P56817 1/20 0.33
EPHX2 P34913 1/20 0.33
KDM4E B2RXH2 3/20 0.33
KIF11 P52732 1/20 0.33
GMNN O75496 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MMP2 P08253 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24363088 0.74 TOP1 (0.41) TOP1SLC40A1MEN1TNFCXCL8
SCHEMBL29631939 0.74 TOP1 (0.41) TOP1SLC40A1MEN1TNFCXCL8
SCHEMBL22372352 0.74 PARP1 (0.38) BACE1CYP2D6
SCHEMBL7487342 0.73 PRMT5 (0.47) MEN1KMT2AKDM4EGMNNLMNA
SCHEMBL20526115 0.73 BACE1 (0.51) MEN1KMT2ABACE1KDM4EKIF11
SCHEMBL10840576 0.68 MAPT (0.48) SLC40A1MEN1TNFCXCL8KMT2A
SCHEMBL27964544 0.67 SLC40A1 (0.46) TOP1SLC40A1MEN1TNFCXCL8
SCHEMBL2569765 0.64 PSMD14 (0.55) SLC40A1KDM4EGMNNLMNATP53
SCHEMBL29935933 0.64 PSMD14 (0.55) SLC40A1KDM4EGMNNLMNATP53
Quinoline SCHEMBL28226310 0.64 ALDH1A1 (0.57) TOP1SLC40A1MEN1TNFCXCL8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030220499-A1 Novel spiro compounds MSD K.K. (JP) 2003-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220499-A1 Novel spiro compounds NPY1R, OPRK1, OPRM1 TOP1 2327/4885SLC40A1 3335/4885MEN1 488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.